Implanting sinoatrial node-like pacemaker cells into the substantia nigra of the brain as a novel therapeutic approach for Parkinson’s disease
- 2 July 2024
- journal article
- research article
- Published by Elsevier in Medical Hypotheses
- Vol. 189
Abstract
No abstract availableKeywords
Funding Information
- Mazandaran University of Medical Sciences
This publication has 22 references indexed in Scilit:
- Parkinson's diseaseThe Lancet, 2021
- Adipose tissue-derived stem cells: a comparative review on isolation, culture, and differentiation methodsCell and Tissue Banking, 2021
- Sinoatrial node pacemaker cells share dominant biological properties with glutamatergic neuronsProtein & Cell, 2021
- Inhibitory potential of plant secondary metabolites on anti-Parkinsonian drug targets: Relevance to pathophysiology, and motor and non-motor behavioural abnormalitiesMedical Hypotheses, 2020
- Diagnosis and Treatment of Parkinson DiseaseJAMA, 2020
- Current aspects of the basic concepts of the electrophysiology of the sinoatrial nodeJournal of Electrocardiology, 2019
- Advances in the treatment of Parkinson's diseaseProgress in Neurobiology, 2007
- Connexin mRNA expression in single dopaminergic neurons of substantia nigra pars compactaNeuroscience Research, 2006
- Transplanted fetal cardiomyocytes as cardiac pacemakerEuropean Journal of Cardio-Thoracic Surgery, 2002
- Stem cells in the treatment of Parkinson’s diseaseBrain Research Bulletin, 2002